Skip to main content

Want a detailed portfolio tracker?

Oncternal Therapeutics (ONCT) Return on Assets (ROA) (2019 - 2024)

Oncternal Therapeutics (ONCT) Return on Assets (ROA) from Jun 30, 2019 to Sep 30, 2024. The TTM Oncternal Therapeutics (ONCT) Return on Assets (ROA) is -54.25%. You can export chart.

Annual ROA

Quarterly ROA

Annual Return on Assets (ROA) change of Oncternal Therapeutics (ONCT)

YearReturn on Assets (ROA)Change
2023-107.49%
+67.06%
2022-64.34%
+92.20%
2021-33.48%
+130.83%
2020-14.50%
-90.78%
2019-157.27%
N/A